227 related articles for article (PubMed ID: 12761689)
1. [Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines. A new diabetes mellitus model (DMM)].
Hauner H; Maxion-Bergemann S; Müller E; Schulz M; Huppertz E; Bergemann R
Dtsch Med Wochenschr; 2003 May; 128(21):1167-72. PubMed ID: 12761689
[TBL] [Abstract][Full Text] [Related]
2. ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents.
Donaghue KC; Wadwa RP; Dimeglio LA; Wong TY; Chiarelli F; Marcovecchio ML; Salem M; Raza J; Hofman PL; Craig ME;
Pediatr Diabetes; 2014 Sep; 15 Suppl 20():257-69. PubMed ID: 25182318
[No Abstract] [Full Text] [Related]
3. Diabetic complications. The importance of glucose control.
Skyler JS
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):243-54. PubMed ID: 8799699
[TBL] [Abstract][Full Text] [Related]
4. [Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus].
Fröhlich-Reiterer EE; Borkenstein MH
Wien Med Wochenschr; 2010 Aug; 160(15-16):414-8. PubMed ID: 20812053
[TBL] [Abstract][Full Text] [Related]
5. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
7. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JAMA; 2002 May; 287(19):2563-9. PubMed ID: 12020338
[TBL] [Abstract][Full Text] [Related]
8. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
Nordwall M; Hyllienmark L; Ludvigsson J
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
[TBL] [Abstract][Full Text] [Related]
9. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
10. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
11. 3: Preventing complications of diabetes.
Bate KL; Jerums G
Med J Aust; 2003 Nov; 179(9):498-503. PubMed ID: 14583083
[TBL] [Abstract][Full Text] [Related]
12. Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.
Zhang X; Zhao S; Huang Y; Ma M; Li B; Li C; Zhu X; Xu X; Chen H; Zhang Y; Zhou C; Zheng Z
J Am Heart Assoc; 2024 Jun; 13(11):e032626. PubMed ID: 38818935
[TBL] [Abstract][Full Text] [Related]
13. Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia.
Hanssen KF; Bangstad HJ; Brinchmann-Hansen O; Dahl-Jørgensen K
Diabet Med; 1992 Oct; 9(8):697-705. PubMed ID: 1395460
[No Abstract] [Full Text] [Related]
14. Diabetes control and complications.
Crofford OB
Annu Rev Med; 1995; 46():267-79. PubMed ID: 7598463
[TBL] [Abstract][Full Text] [Related]
15. Teenage girls with type 1 diabetes have poorer metabolic control than boys and face more complications in early adulthood.
Samuelsson U; Anderzén J; Gudbjörnsdottir S; Steineck I; Åkesson K; Hanberger L
J Diabetes Complications; 2016 Jul; 30(5):917-22. PubMed ID: 27052153
[TBL] [Abstract][Full Text] [Related]
16. Lessons from the Diabetes Control and Complications Trial.
Santiago JV
Diabetes; 1993 Nov; 42(11):1549-54. PubMed ID: 8405693
[No Abstract] [Full Text] [Related]
17. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.
Eastman RC; Javitt JC; Herman WH; Dasbach EJ; Copley-Merriman C; Maier W; Dong F; Manninen D; Zbrozek AS; Kotsanos J; Garfield SA; Harris M
Diabetes Care; 1997 May; 20(5):735-44. PubMed ID: 9135935
[TBL] [Abstract][Full Text] [Related]
18. Orthostatic hypotension in diabetic patients-10-year follow-up study.
Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
Johnson L; Rayner B
Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
[TBL] [Abstract][Full Text] [Related]
20. Pattern of long-term complications in Sudanese insulin-treated diabetic patients.
Elbagir MN; Eltom MA; Mahadi EO; Berne C
Diabetes Res Clin Pract; 1995 Oct; 30(1):59-67. PubMed ID: 8745207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
